Grant’s Current Yield Podcast cover image

Value in biotech

Grant’s Current Yield Podcast

CHAPTER

Unicure: The Best Year Ever for Intrinsic Value

Mark O'Mara: I'm intrigued by one of the stocks that I know that you own and like, and indeed perhaps regard as one of your favorites. That's something called Unicure, which is Amsterdam based in trades on the NASDAQ. And my due diligence on this particular name, Mark, insisted of looking at the stock chart. And I see it was 82 in 2019, and it's not quite 22 today. He says even though they had a year when they executed extremely well, arguably create a lot of intrinsic value, the stock hasn't reacted at all. But he says growth investors will find them.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner